BLENREP vs REVLIMID

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 10, 2026·How we rate

Possible drug interaction. BLENREP and REVLIMID are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BLENREP	REVLIMID
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BELANTAMAB MAFODOTIN-BLMF	LENALIDOMIDE
Manufacturer	Glaxosmithkline	Bristol Myers Squibb
Dosage forms	Injectable	Capsule
Drug class	—	Thalidomide Analog
Boxed warning	Boxed warning	Boxed warning
Half-life	—	about 3 hours in healthy subjects, and 3 to 5 hours in patients with multiple myeloma, MDS, or mantle cell lymphoma
Treats	Multiple Myeloma	Multiple Myeloma, Myelodysplastic Syndromes, Mantle-Cell Lymphoma

blenrep revlimid

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

BELANTAMAB MAFODOTIN-BLMF

LENALIDOMIDE

Manufacturer

Glaxosmithkline

Bristol Myers Squibb

Dosage forms

Injectable

Capsule

Drug class

—

Thalidomide Analog

Boxed warning

Half-life

—

about 3 hours in healthy subjects, and 3 to 5 hours in patients with multiple myeloma, MDS, or mantle cell lymphoma

Treats

Multiple Myeloma

Multiple Myeloma, Myelodysplastic Syndromes, Mantle-Cell Lymphoma

Frequently asked questions

Which is better-rated, Blenrep or Revlimid?

Blenrep and Revlimid are tied at 3.6 out of 5 by our independent rating.

What is the difference between Blenrep and Revlimid?

Blenrep contains Belantamab Mafodotin-Blmf, while Revlimid contains Lenalidomide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.